David Franklin (scientist) (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "David Franklin (scientist)" in English language version.

refsWebsite

Global rank English rank

6nih.gov

4^th place

4bloomberg.com

99^th place

77^th place

3doi.org

2^nd place

2web.archive.org

1^st place

1usatoday.com

41^st place

34^th place

1law360.com

6,282^nd place

3,410^th place

1google.com

163^rd place

185^th place

1postschell.com

low place

1csuohio.edu

low place

7,370^th place

1amcp.org

low place

1fda.gov

447^th place

338^th place

1ucsf.edu

5,479^th place

3,911^th place

1annals.org

low place

amcp.org

Mack A (2003). "Examination of the evidence for off-label use of gabapentin" (PDF). J Manag Care Pharm. 9 (6): 559–68. doi:10.18553/jmcp.2003.9.6.559. PMC 10437292. PMID 14664664. Archived from the original (PDF) on 2010-09-17. Retrieved 2009-03-18.

annals.org

Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry Documents -- Steinman et al. 145 (4): 284 -- Annals of Internal Medicine

bloomberg.com

David Evans for Bloomberg News. November 9, 2009. Pfizer Broke the Law by Promoting Drugs for Unapproved Uses
Bob Van Voris and Janelle Lawrence for Bloomberg News. March 26, 2010 Pfizer Told to Pay $142.1 Million for Neurontin Marketing Fraud
Jef Feeley J for Bloomberg News. May 17, 2010 Pfizer Settles Neurontin Suit Over Minister's Death
Jef Feeley and Janelle Lawrence for Bloomberg News. April 2, 2010 Pfizer Agrees to First Settlement of a Neurontin-Related Suicide Lawsuit

csuohio.edu

engagedscholarship.csuohio.edu

David S. Torborg The Dark Side of the Boom: The Peculiar Dilemma of Modern False Claims Act Litigation 26 J.L. & Health 181 (2013

doi.org

Lenzer J (2003-03-22). "Whistleblower charges drug company with deceptive practices". BMJ. 326 (7390): 620. doi:10.1136/bmj.326.7390.620. PMC 1125531. PMID 12649230.
Lenzer J (2004-05-22). "Pfizer pleads guilty, but drug sales continue to soar". BMJ. 328 (7450): 1217. doi:10.1136/bmj.328.7450.1217. PMC 416587. PMID 15155480.
Mack A (2003). "Examination of the evidence for off-label use of gabapentin" (PDF). J Manag Care Pharm. 9 (6): 559–68. doi:10.18553/jmcp.2003.9.6.559. PMC 10437292. PMID 14664664. Archived from the original (PDF) on 2010-09-17. Retrieved 2009-03-18.

fda.gov

FD&C Act 21 USC §331, Federal Food, Drug, and Cosmetics Act Sec. 301 Prohibited acts{{citation}}: CS1 maint: numeric names: authors list (link)

google.com

Google Books, Books citing David Franklin and Neurontin {{citation}}: |author= has generic name (help)

law360.com

Kira Lerner for Law360. April 17, 2014 Pfizer, Kaiser End Neurontin Off-Label Suit With Fee Deal

nih.gov

ncbi.nlm.nih.gov

Lenzer J (2003-03-22). "Whistleblower charges drug company with deceptive practices". BMJ. 326 (7390): 620. doi:10.1136/bmj.326.7390.620. PMC 1125531. PMID 12649230.
Lenzer J (2004-05-22). "Pfizer pleads guilty, but drug sales continue to soar". BMJ. 328 (7450): 1217. doi:10.1136/bmj.328.7450.1217. PMC 416587. PMID 15155480.
Mack A (2003). "Examination of the evidence for off-label use of gabapentin" (PDF). J Manag Care Pharm. 9 (6): 559–68. doi:10.18553/jmcp.2003.9.6.559. PMC 10437292. PMID 14664664. Archived from the original (PDF) on 2010-09-17. Retrieved 2009-03-18.

pubmed.ncbi.nlm.nih.gov

Lenzer J (2003-03-22). "Whistleblower charges drug company with deceptive practices". BMJ. 326 (7390): 620. doi:10.1136/bmj.326.7390.620. PMC 1125531. PMID 12649230.
Lenzer J (2004-05-22). "Pfizer pleads guilty, but drug sales continue to soar". BMJ. 328 (7450): 1217. doi:10.1136/bmj.328.7450.1217. PMC 416587. PMID 15155480.
Mack A (2003). "Examination of the evidence for off-label use of gabapentin" (PDF). J Manag Care Pharm. 9 (6): 559–68. doi:10.18553/jmcp.2003.9.6.559. PMC 10437292. PMID 14664664. Archived from the original (PDF) on 2010-09-17. Retrieved 2009-03-18.

postschell.com

Joseph JN, et al. Enforcement Related to Off-Label Marketing and Use of Drugs and Devices: Where Have We Been and Where Are We Going? Archived 2016-03-04 at the Wayback Machine Journal of Health & Life Sciences Law 2(2):73-108. January 2009

ucsf.edu

dida.library.ucsf.edu

Drug Industry Document Archive

usatoday.com

images.usatoday.com

Chitose Suzuki, USAToday/AP, "Photo: Dr. David P. Franklin at Pfizer guilty plea press conference (5/12/2004)", USA Today

web.archive.org

Joseph JN, et al. Enforcement Related to Off-Label Marketing and Use of Drugs and Devices: Where Have We Been and Where Are We Going? Archived 2016-03-04 at the Wayback Machine Journal of Health & Life Sciences Law 2(2):73-108. January 2009
Mack A (2003). "Examination of the evidence for off-label use of gabapentin" (PDF). J Manag Care Pharm. 9 (6): 559–68. doi:10.18553/jmcp.2003.9.6.559. PMC 10437292. PMID 14664664. Archived from the original (PDF) on 2010-09-17. Retrieved 2009-03-18.